
Patrick Alan Hagen, MD
Medical Oncology, Hematology, Hematology & Oncology, Internal Medicine
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Primary Contact
888-584-7888
Appointments (New Patients Welcome)
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Primary Contact
888-584-7888Services & Specialties
Areas of Specialization
- Hematology
- Hematology & Oncology
- Internal Medicine
- Medical Oncology
Clinical Interests
Conditions Treated
- cancer chemotherapy
- bone marrow aspiration
- stem cell harvest
- cellular therapy
- cellular therapy - allogeneic
- cellular therapy - autologous
- cellular therapy - chimeric antigen T-cell (CAR-T)
- bone marrow biopsy
Locations & Contact
Primary Location
Loyola University Medical Center
2160 S First Ave
Maywood
, IL 60153
Loyola Cancer Care & Research at the Marjorie G. Weinberg Cancer Center at Melrose Park
715 W N Ave
Melrose Park
, IL 60160
About
My work at Loyola University incorporates both pre-clinical and clinical research as well as direct patient care. I am passionate about working with patients to find the best treatment choice tailored to each individual. My focus is primarily on plasma cell disorders including monoclonal gammopathy of unknown significance (MGUS), smoldering myeloma, multiple myeloma, plasma cell leukemia, amyloidosis (both systemic and ATTR), light chain deposition disease, and POEMS disease. However, I see patients for all malignant hematology conditions including acute and chronic leukemia, non-hodgkin and hodgkins lymphoma, a well as MDS and aplastic anemia. In particular, I focus on the role of high dose chemotherapy and autologous or allogeneic transplant as well as cellular therapy (CAR-T) in the care of patients. Further, it is my goal that every patient be offered and ideally treated on a clinical trial in order to improve patient outcomes. I am involved in translational as well as early and late phase clinical trial development.
Finally, I truly enjoy working with referring physicians and am passionate about finding the best treatment for mutual patients either here at Loyola or ideally locally if possible. I am always available to discuss the best care options for patients regardless of intent to refer to us for a second opinion or clinical trial opportunities.
Academic Title
Associate Professor
Leadership Title
Associate Director of the Cardinal Bernardin Cancer Center Clinical Trials Office
Interim Director of the Transplantation and Cellular Therapy Program
Ages Seen
Additional Resources
Education & Certifications
Education
Education:
St George's University School of Medicine
(2011)
Residency:
University of Minnesota Medical School
(2014)
Fellowship:
Loyola University Stritch School of Medicine
(2017)
Board Certifications
Hematology, Hematology, American Board of Internal Medicine Subspecialty (2020)
Medical Oncology, Medical Oncology, American Board of Internal Medicine Subspecialty (2017)
Internal Medicine, Internal Medicine, American Board of (2014)
Provider Groups
Loyola Medicine Physician
Loyola Physician Partners
Publications
- Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice. Liu, S.; Joshi, K.; Zhang, L.; Li, W.; Mack, R.; Runde, A.; Hagen, P. A.; Barton, K.; Breslin, P.; Ji, H. L.; Kini, A. R.; Wang, Z.; Zhang, J.; Cell death & disease
- Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia. Li, Y.; Seet, C. S.; Mack, R.; Joshi, K.; Runde, A. P.; Hagen, P. A.; Barton, K.; Breslin, P.; Kini, A.; Ji, H. L.; Zhang, J.; Stem cell reports
- Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation. Shaw, R.; Haque, A. R.; Luu, T.; O'Connor, T. E.; Hamidi, A.; Fitzsimons, J.; Varda, B.; Kwon, D.; Whitcomb, C.; Gregorowicz, A.; Roloff, G. W.; Bemiss, B. C.; Kallwitz, E. R.; Hagen, P. A.; Berg, S.; Frontiers in oncology
- The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple Myeloma. Hagen, P. A.; Stiff, P.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
- Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors. Hagen, P. A.; Adams, W.; Smith, S.; Tsai, S.; Stiff, P.; Bone marrow transplantation